Global Hydrocortisone Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Hydrocortisone Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Cream
  • 1.4.3 Injection
  • 1.4.4 Table
• 1.5 Market by Application
  • 1.5.1 Global Hydrocortisone Market Share by Application (2014-2025)
  • 1.5.2 Adrenocortical Dysfunction
  • 1.5.3 Adrenergic Syndrome
  • 1.5.4 High Blood Calcium
  • 1.5.5 Thyroiditis
  • 1.5.6 Rheumatoid Arthritis
  • 1.5.7 Dermatitis
  • 1.5.8 Asthma and Chronic Obstructive Pulmonary Disease
  • 1.5.9 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Hydrocortisone Market Size
• 2.2 Hydrocortisone Growth Trends by Regions
  • 2.2.1 Hydrocortisone Market Size by Regions (2014-2025)
  • 2.2.2 Hydrocortisone Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Hydrocortisone Market Size by by Players
  • 3.1.1 Global Hydrocortisone Revenue by by Players (2014-2019)
  • 3.1.2 Global Hydrocortisone Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Hydrocortisone Market Concentration Ratio (CR5 and HHI)
• 3.2 Hydrocortisone Key Players Head office and Area Served
• 3.3 Key Players Hydrocortisone Product/Solution/Service
• 3.4 Date of Enter into Hydrocortisone Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Hydrocortisone Market Size by Type (2014-2019)
• 4.2 Global Hydrocortisone Market Size by Application (2014-2019)

5 United States

• 5.1 United States Hydrocortisone Market Size (2014-2019)
• 5.2 Hydrocortisone Key Players in United States
• 5.3 United States Hydrocortisone Market Size by Type
• 5.4 United States Hydrocortisone Market Size by Application

6 Europe

• 6.1 Europe Hydrocortisone Market Size (2014-2019)
• 6.2 Hydrocortisone Key Players in Europe
• 6.3 Europe Hydrocortisone Market Size by Type
• 6.4 Europe Hydrocortisone Market Size by Application

7 China

• 7.1 China Hydrocortisone Market Size (2014-2019)
• 7.2 Hydrocortisone Key Players in China
• 7.3 China Hydrocortisone Market Size by Type
• 7.4 China Hydrocortisone Market Size by Application

8 Japan

• 8.1 Japan Hydrocortisone Market Size (2014-2019)
• 8.2 Hydrocortisone Key Players in Japan
• 8.3 Japan Hydrocortisone Market Size by Type
• 8.4 Japan Hydrocortisone Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Hydrocortisone Market Size (2014-2019)
• 9.2 Hydrocortisone Key Players in Southeast Asia
• 9.3 Southeast Asia Hydrocortisone Market Size by Type
• 9.4 Southeast Asia Hydrocortisone Market Size by Application

10 India

• 10.1 India Hydrocortisone Market Size (2014-2019)
• 10.2 Hydrocortisone Key Players in India
• 10.3 India Hydrocortisone Market Size by Type
• 10.4 India Hydrocortisone Market Size by Application

11 Central & South America

• 11.1 Central & South America Hydrocortisone Market Size (2014-2019)
• 11.2 Hydrocortisone Key Players in Central & South America
• 11.3 Central & South America Hydrocortisone Market Size by Type
• 11.4 Central & South America Hydrocortisone Market Size by Application

12 International Players Profiles

• 12.1 Pfizer
  • 12.1.1 Pfizer Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Hydrocortisone Introduction
  • 12.1.4 Pfizer Revenue in Hydrocortisone Business (2014-2019)
  • 12.1.5 Pfizer Recent Development
• 12.2 Sanofi
  • 12.2.1 Sanofi Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Hydrocortisone Introduction
  • 12.2.4 Sanofi Revenue in Hydrocortisone Business (2014-2019)
  • 12.2.5 Sanofi Recent Development
• 12.3 Teva
  • 12.3.1 Teva Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Hydrocortisone Introduction
  • 12.3.4 Teva Revenue in Hydrocortisone Business (2014-2019)
  • 12.3.5 Teva Recent Development
• 12.4 Akorn
  • 12.4.1 Akorn Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Hydrocortisone Introduction
  • 12.4.4 Akorn Revenue in Hydrocortisone Business (2014-2019)
  • 12.4.5 Akorn Recent Development
• 12.5 GSK
  • 12.5.1 GSK Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Hydrocortisone Introduction
  • 12.5.4 GSK Revenue in Hydrocortisone Business (2014-2019)
  • 12.5.5 GSK Recent Development
• 12.6 Bausch and Lomb
  • 12.6.1 Bausch and Lomb Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Hydrocortisone Introduction
  • 12.6.4 Bausch and Lomb Revenue in Hydrocortisone Business (2014-2019)
  • 12.6.5 Bausch and Lomb Recent Development
• 12.7 Bayer Pharmas
  • 12.7.1 Bayer Pharmas Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Hydrocortisone Introduction
  • 12.7.4 Bayer Pharmas Revenue in Hydrocortisone Business (2014-2019)
  • 12.7.5 Bayer Pharmas Recent Development
• 12.8 Macleods Pharmaceuticals
  • 12.8.1 Macleods Pharmaceuticals Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Hydrocortisone Introduction
  • 12.8.4 Macleods Pharmaceuticals Revenue in Hydrocortisone Business (2014-2019)
  • 12.8.5 Macleods Pharmaceuticals Recent Development
• 12.9 Casper Pharma
  • 12.9.1 Casper Pharma Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Hydrocortisone Introduction
  • 12.9.4 Casper Pharma Revenue in Hydrocortisone Business (2014-2019)
  • 12.9.5 Casper Pharma Recent Development
• 12.10 Dow Pharma
  • 12.10.1 Dow Pharma Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Hydrocortisone Introduction
  • 12.10.4 Dow Pharma Revenue in Hydrocortisone Business (2014-2019)
  • 12.10.5 Dow Pharma Recent Development
• 12.11 Fougera Pharms
• 12.12 Hikma Intl Pharms
• 12.13 Impax Labs
• 12.14 Ivax Pharms
• 12.15 Lannett
• 12.16 Merck
• 12.17 Novartis
• 12.18 Salix Pharms
• 12.19 Sandoz
• 12.20 TARO
• 12.21 Valeant
• 12.22 Wockhardt
• 12.23 Farmak JSC
• 12.24 Solvay Pharma
• 12.25 Alcon
• 12.26 Paladin Labs
• 12.27 Adcock Ingram
• 12.28 ADARE Pharmaceuticals
• 12.29 Aspen Holdings
• 12.30 Astellas Pharma

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer